“Highly esteemed for its handling of contentious IP matters, acting on both litigation and international arbitrations. Also strong on the consultancy side.”
“Outstanding team.”
“Smart and technically very strong.”
“The team has excellent knowledge of the legal situation, provides fast feedback, shows a strong initiative and pushes for solutions.”
“A courtroom favourite among major life sciences players, the team also boasts first-rate arbitration capabilities.”
Our Intellectual Property Group focuses on litigation and arbitration of intellectual property and licensing disputes. Alongside this, the IP team is active in complex licensing deals and major transactional matters, often in combination with the firm’s M&A team. The IP team works across a wide range of sectors and has particular industry expertise in the life sciences and luxury goods sectors.
We represent clients in litigation and arbitration proceedings that involve:
We also assist clients in the following areas:
We have significant expertise in the following industry sectors:
22.10.2024
Schellenberg Wittmer is proud to announce that our partner Lorenza Ferrari Hofer was elected president of AIPPI International.
27.09.2024
Schellenberg Wittmer is pleased to announce the addition of three new Partners and one Counsel to our team.
05.09.2024
Schellenberg Wittmer advised Boehringer Ingelheim, one of the largest pharmaceutical companies, on the acquisition of Saiba Animal Health AG.
The group and leading practitioners are highly ranked and recognised among leading law firms in global directories and publications:
